Immunocore Holdings plc (IMCR) has a consensus analyst rating of Buy, based on 14 analysts covering the stock. Of those, 9 recommend buying, 5 recommend holding, and 0 recommend selling.
The analyst consensus price target for IMCR is $47.25, representing a +49.1% upside from the current price of $31.69. Price targets range from a low of $36.00 to a high of $60.00.
